H. pylori eradication reduced gastric cancer incidence

Helicobacter pylori eradication therapy reduced the incidence of gastric cancer in asymptomatic Asian patients, according to recent study data.

Gastric cancer is the third commonest cause of death from cancer, and H. pylori is causally implicated in its etiology,” study researcher Alexander C. Ford, MBChB, MD, FRCP, associate professor, Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, United Kingdom, told “The World Health Organization classed H. pylori as a human carcinogen 20 years ago, but, as yet, no country at high risk for gastric cancer (eg, China, Japan, Korea) has adopted testing for and treatment of H. pylori in the general population as a means of preventing this disease.”

To read the full article visit here:

PCSG Podcast Ingest